TipRanks
Go Ultimate55% OFF

Bharat Rasayan Limited (BHARATRAS) AI Stock Analysis

IN:BHARATRAS

Bharat Rasayan Limited

(NSE:BHARATRAS)

Select Model
Rating:74Outperform
Price Target:INR 1,044.00▲(9.87% Upside)
Action:reiterated
Date:08/28/26

The overall score is driven primarily by strong financial performance, with rising revenues and profits, double‑digit margins, and an exceptionally low‑debt balance sheet that supports resilience through industry cycles. Attractive valuation, featuring a low earnings multiple and a reasonable dividend yield, further underpins the stock’s appeal. These strengths are partially offset by weaker technicals—price below key moving averages, negative momentum indicators, and elevated volatility—and by the historical volatility in cash flows and recent margin and cash‑generation softness, which temper the score below the highest tier.

Positive Factors
Very Low LeverageA near-zero debt-to-equity position gives Bharat Rasayan substantial financial flexibility and low solvency risk. The stronger capital base can help the company withstand agrochemical cycles, fund operations internally, and preserve strategic options without heavy interest or refinancing burdens.
Negative Factors
Volatile Revenue GrowthUneven revenue performance shows that Bharat Rasayan is exposed to agrochemical demand cycles and changing product or market conditions. Such volatility makes capacity planning and earnings visibility less consistent, potentially limiting the predictability of growth over the next several quarters.

Bharat Rasayan Limited (BHARATRAS) vs. iShares MSCI India ETF (INDA)

-70%-60%-50%-40%-30%-20%-10%0%10%IN:BHARATRAS-66.36%INDA-12.02%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
INR 15.57B
Dividend Yield
0.05%
Average Volume (3M)
1,806
Price to Earnings (P/E)
6.9
Beta (1Y)
1.52
Revenue Growth
-5.17%
EPS Growth
4.24%
Country
India
Employees
903
Sector
General
Sector Strength
55
Industry
Agricultural Inputs

Bharat Rasayan Limited Business Overview & Revenue Model

Company Description

Established in 1989 and headquartered in New Delhi, India, Bharat Rasayan Limited is a key producer and distributor of agrochemical products. The company specializes in technical grade pesticides, encompassing insecticides, herbicides, and fungicides...

How the Company Makes Money

Bharat Rasayan Limited primarily makes money by manufacturing and selling agrochemical products across the crop protection value chain. Its core revenue stream is the sale of technical-grade active ingredients (i.e., concentrated, technical material...

Bharat Rasayan Limited Financial Statement Overview

Summary

Financial performance is strong overall, with revenue and net profit rising in FY 2025 and FY 2026, attractive double‑digit profit margins, and an exceptionally low‑leverage balance sheet. However, gross and operating margin compression versus prior peak years and volatile operating and free cash flow, including a negative outturn in FY 2022 and a notable decline in FY 2026, prevent a top‑tier score.

Income Statement

78Positive

Balance Sheet

88Very Positive

Cash Flow

70Positive
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue12.03B12.42B11.73B10.45B12.34B12.95B
Gross Profit3.01B3.19B3.96B3.24B3.95B3.69B
EBITDA1.95B2.24B2.01B1.38B2.06B2.66B
Net Income1.43B1.46B1.41B955.10M1.25B1.76B
Balance Sheet
Total Assets014.33B14.08B11.97B10.74B10.86B
Cash, Cash Equivalents and Short-Term Investments2.73B2.73B2.86B1.41B485.96M66.88M
Total Debt012.26M852.19M804.74M279.37M1.74B
Total Liabilities-12.75B1.58B2.78B2.10B1.80B3.16B
Stockholders Equity12.75B12.75B11.30B9.88B8.93B7.70B
Cash Flow
Free Cash Flow-161.72M545.22M1.32B140.26M1.90B-1.21B
Operating Cash Flow249.00K1.28B1.68B410.76M2.13B-654.55M
Investing Cash Flow-173.93M-963.94M-1.57B-897.00M-605.49M511.36M
Financing Cash Flow23.25M-846.16M41.22M489.57M-1.52B-247.85M

Bharat Rasayan Limited Technical Analysis

Technical Analysis SentimentNegative
Last Price950.20

Price Trends

50DMA1095.26Negative
100DMA1222.03Negative
200DMA1384.12Negative

Market Momentum

MACD-43.58Negative
RSI27.78Positive
STOCH12.41Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:BHARATRAS, the sentiment is Negative. The current price of 950.20 is below the 20-day moving average (MA) of 971.36, below the 50-day MA of 1095.26, and below the 200-day MA of 1384.12, indicating a bearish trend. The MACD of -43.58 indicates Negative momentum. The RSI at 27.78 is Positive, neither overbought nor oversold. The STOCH value of 12.41 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:BHARATRAS.

Bharat Rasayan Limited Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

IN:BHARATRAS against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
IN:BHARATRASIN:BHARATRAS74OutperformINR 15.49B6.86―0.05%-5.17%4.24%
IN:DHANUKAIN:DHANUKA73OutperformINR 43.75B16.48―0.20%-5.63%-11.38%
IN:IPLIN:IPL66NeutralINR 12.97B12.05―0.67%17.05%9.10%
IN:RALLISIN:RALLIS63NeutralINR 35.75B18.14―1.63%6.82%11.93%
IN:INSECTICIDIN:INSECTICID58NeutralINR 15.10B11.82―0.39%1.26%-16.43%
IN:PIINDIN:PIIND56NeutralINR 316.94B27.34―0.48%-16.57%-27.71%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%

* General Sector Average

Performance Comparison

-60%-40%-20%0%IN:BHARATRASIN:DHANUKAIN:INSECTICIDIN:IPLIN:PIINDIN:RALLISDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
IN:BHARATRAS and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
IN:BHARATRASBharat Rasayan Limited931.80-1752.46-65.29%
IN:DHANUKADhanuka Agritech Limited981.50-322.04-24.70%
IN:INSECTICIDInsecticides (India) Limited519.10-200.11-27.82%
IN:IPLIndia Pesticides Ltd.112.60-77.23-40.68%
IN:PIINDPI Industries Limited2089.00-1580.52-43.07%
IN:RALLISRallis India Limited183.85-75.13-29.01%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Aug 28, 2026